BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34198248)

  • 1. Trends in acute ischemic stroke treatments and mortality in the United States from 2012 to 2018.
    Anand SK; Benjamin WJ; Adapa AR; Park JV; Wilkinson DA; Daou BJ; Burke JF; Pandey AS
    Neurosurg Focus; 2021 Jul; 51(1):E2. PubMed ID: 34198248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-specific trends in intravenous thrombolysis and mechanical thrombectomy utilization in acute ischemic stroke in children under age 18.
    Kaur N; Patel S; Ayanbadejo MO; Hoffman H; Akano E; Anikpezie N; Aneni E; Lamikanra O; Wee C; Albright K; Khandelwal P; Latorre JG; Chaturvedi S; Otite FO
    Int J Stroke; 2023 Apr; 18(4):469-476. PubMed ID: 36250237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Procoagulant Blood Biomarkers After Mechanical Thrombectomy.
    Welch JC; Erkmen K; Gentile N
    J Stroke Cerebrovasc Dis; 2021 Jun; 30(6):105772. PubMed ID: 33839379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-Year Trend in Age, Sex, and Racial Disparity in tPA (Alteplase) and Thrombectomy Use Following Stroke in the United States.
    Otite FO; Saini V; Sur NB; Patel S; Sharma R; Akano EO; Anikpezie N; Albright K; Schmidt E; Hoffman H; Gould G; Khandelwal P; Latorre JG; Malik AM; Sacco RL; Chaturvedi S
    Stroke; 2021 Aug; 52(8):2562-2570. PubMed ID: 34078107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanical Thrombectomy in Acute Ischemic Stroke Patients Greater than 90 Years of Age: Experience in 26 Patients in a Large Tertiary Care Center and Outcome Comparison with Younger Patients.
    Sweid A; Weinberg JH; Xu V; Shivashankar K; Alexander TD; Khalife J; Elmer N; Gooch MR; Herial N; Chalouhi N; Jabbour P; Rosenwasser RH; Tjoumakaris S
    World Neurosurg; 2020 Jan; 133():e835-e841. PubMed ID: 31614218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France.
    Kaboré N; Marnat G; Rouanet F; Barreau X; Verpillot E; Menegon P; Maachi I; Berge J; Sibon I; Bénard A
    Rev Neurol (Paris); 2019 Apr; 175(4):252-260. PubMed ID: 30642680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanical Thrombectomy Versus Best Medical Management for Acute Ischemic Stroke in Elderly Patients: A Cost-Effectiveness Analysis.
    Lim J; Monteiro A; Ruggiero N; Baig AA; Aguirre AO; McPheeters MJ; Waqas M; Vakharia K; Snyder KV; Siddiqui AH; Levy EI; Davies JM
    World Neurosurg; 2023 Jul; 175():e730-e737. PubMed ID: 37037370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in the Use of Mechanical Thrombectomy Alone Compared with Adjunctive Intravenous Thrombolysis in Acute Ischemic Stroke in the United States.
    Wahood W; Rizvi AA; Alexander Y; Alvi MA; Rajjoub KR; Cloft H; Rabinstein AA; Brinjikji W
    AJNR Am J Neuroradiol; 2021 Dec; 42(12):2175-2180. PubMed ID: 34737182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Tissue Plasminogen Activator for Large Vessel Ischemic Stroke - Is There Still a Role?
    Sawyer RN
    Neurosurgery; 2019 Jul; 85(suppl_1):S34-S37. PubMed ID: 31197340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct Mechanical Intervention Versus Combined Intravenous and Mechanical Intervention in Large Artery Anterior Circulation Stroke: A Matched-Pairs Analysis.
    Broeg-Morvay A; Mordasini P; Bernasconi C; Bühlmann M; Pult F; Arnold M; Schroth G; Jung S; Mattle HP; Gralla J; Fischer U
    Stroke; 2016 Apr; 47(4):1037-44. PubMed ID: 26906917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous Recombinant Tissue-Type Plasminogen Activator: Influence on Outcome in Anterior Circulation Ischemic Stroke Treated by Mechanical Thrombectomy.
    Ferrigno M; Bricout N; Leys D; Estrade L; Cordonnier C; Personnic T; Kyheng M; Henon H
    Stroke; 2018 Jun; 49(6):1377-1385. PubMed ID: 29748424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging temporal trends in tissue plasminogen activator use: Results from the BASIC project.
    Domino JS; Baek J; Meurer WJ; Garcia N; Morgenstern LB; Campbell M; Lisabeth LD
    Neurology; 2016 Nov; 87(21):2184-2191. PubMed ID: 27770075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of two stroke cohorts cared for by two different specialties in a practice-based tele-stroke population.
    Atallah E; Bekelis K; Saad H; Chalouhi N; Dang S; Li J; Kumar A; Turpin J; Barsoom R; Tjoumakaris S; Hasan D; Deprince M; Labella G; Rosenwasser RH; Jabbour P
    Clin Neurol Neurosurg; 2018 May; 168():67-71. PubMed ID: 29525730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temporal trends in patient characteristics and treatment with intravenous thrombolysis among acute ischemic stroke patients at Get With The Guidelines-Stroke hospitals.
    Schwamm LH; Ali SF; Reeves MJ; Smith EE; Saver JL; Messe S; Bhatt DL; Grau-Sepulveda MV; Peterson ED; Fonarow GC
    Circ Cardiovasc Qual Outcomes; 2013 Sep; 6(5):543-9. PubMed ID: 24046398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age differences in utilization and outcomes of tissue-plasminogen activator and mechanical thrombectomy in acute ischemic stroke.
    Nagaraja N; Patel UK; Chaturvedi S
    J Neurol Sci; 2021 Jan; 420():117262. PubMed ID: 33333325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reasons for Not Performing Mechanical Thrombectomy: A Population-Based Study of Stroke Codes.
    Guisado-Alonso D; Martínez-Domeño A; Prats-Sánchez L; Delgado-Mederos R; Camps-Renom P; Abilleira S; de la Ossa NP; Ramos-Pachón A; Cardona P; Rodríguez-Campello A; Molina CA; Rudilosso S; Martí-Fàbregas J;
    Stroke; 2021 Aug; 52(9):2746-2753. PubMed ID: 34289711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-Hospital Outcomes and Recurrence of Acute Ischemic Stroke in Patients With Solid Organ Malignancy.
    Garg A; Chopra S; Starr M; Rocha M; Dawod J; Leira E; Shaban A
    Neurology; 2022 Jul; 99(4):e393-e401. PubMed ID: 35487697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Outcomes After Mechanical Thrombectomy Alone or Combined with Intravenous Thrombolysis and Mechanical Thrombectomy for Patients with Acute Ischemic Stroke due to Large Vessel Occlusion.
    Choi JH; Im SH; Lee KJ; Koo JS; Kim BS; Shin YS
    World Neurosurg; 2018 Jun; 114():e165-e172. PubMed ID: 29510288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive rural-urban disparity in acute stroke care.
    Gonzales S; Mullen MT; Skolarus L; Thibault DP; Udoeyo U; Willis AW
    Neurology; 2017 Jan; 88(5):441-448. PubMed ID: 28053009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endovascular thrombectomy for acute ischemic stroke in failed intravenous tissue plasminogen activator versus non-intravenous tissue plasminogen activator patients: revascularization and outcomes stratified by the site of arterial occlusions.
    Shi ZS; Loh Y; Walker G; Duckwiler GR;
    Stroke; 2010 Jun; 41(6):1185-92. PubMed ID: 20431084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.